På baggrund af de 28 års kliniske erfaringer med den eksisterende formulering af UMAN BIG fandt CHMP, at sikkerheden for mennesker er blevet grundigt vurderet.
The CHMP considered that based on the 28 years of clinical experience with the existing formulation of UMAN BIG, the safety in humans can be considered to have been extensively assessed.